[go: up one dir, main page]

PE20080899A1 - Composiciones en nanoparticulas - Google Patents

Composiciones en nanoparticulas

Info

Publication number
PE20080899A1
PE20080899A1 PE2007001099A PE2007001099A PE20080899A1 PE 20080899 A1 PE20080899 A1 PE 20080899A1 PE 2007001099 A PE2007001099 A PE 2007001099A PE 2007001099 A PE2007001099 A PE 2007001099A PE 20080899 A1 PE20080899 A1 PE 20080899A1
Authority
PE
Peru
Prior art keywords
refers
therapeutic agent
fraction
divalent cation
nanoparticles
Prior art date
Application number
PE2007001099A
Other languages
English (en)
Inventor
Saran Kumar
Wen-Chung Shieh
Seema Tomer
Joseph Lawrence Zielinski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20080899A1 publication Critical patent/PE20080899A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA BASADA EN NANOPARTICULAS, QUE CONTIENE: A) UNA MATRIZ DE CATION DIVALENTE QUE COMPRENDE IONES DE CALCIO, B) UN AGENTE TERAPEUTICO QUE PUEDE SER HIDROFILO, LIPOFILO, PREFERENTEMENTE UN COMPUESTO DE FORMULA I, DONDE R1 ES UN HETEROARILO DE 5 MIEMBROS, R2 ES H, HIDROXILO, AMINO, TIOALQUILO INFERIOR O HALOGENO; C) UN RECUBRIMIENTO POLIMERICO HIDROFILO QUE COMPRENDE PLGA Y OPCIONALMENTE UNA FRACCION DE AFINIDAD HACIA EL OBJETIVO PARA EL CUAL SE DESTINE LA TERAPIA. LA FRACCION DE AFINIDAD ES UN RECEPTOR, UN LIGANDO DE FACTOR DE CRECIMIENTO ENDOTELIAL. UN AGENTE TERAPEUTICO PREFERIDO ES ACIDO ZELEDRONICO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION TIENE UN TAMANO DE PARTICULA DE 10 A 500 nm Y ES UTIL PARA EL TRATAMIENTO DE TUMORES SOLIDOS
PE2007001099A 2006-08-17 2007-08-15 Composiciones en nanoparticulas PE20080899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82267406P 2006-08-17 2006-08-17

Publications (1)

Publication Number Publication Date
PE20080899A1 true PE20080899A1 (es) 2008-06-25

Family

ID=39313134

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001099A PE20080899A1 (es) 2006-08-17 2007-08-15 Composiciones en nanoparticulas

Country Status (15)

Country Link
US (1) US20100166865A1 (es)
EP (1) EP2054043A2 (es)
JP (1) JP2010501004A (es)
KR (1) KR20090041437A (es)
CN (1) CN101500546A (es)
AR (1) AR062452A1 (es)
AU (1) AU2007319701A1 (es)
BR (1) BRPI0716046A2 (es)
CA (1) CA2659407A1 (es)
CL (1) CL2007002371A1 (es)
MX (1) MX2009001630A (es)
PE (1) PE20080899A1 (es)
RU (1) RU2009109353A (es)
TW (1) TW200815047A (es)
WO (1) WO2008060734A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010019718A2 (en) 2008-08-13 2010-02-18 California Institute Of Technology Carrier nanoparticles and related compositions, methods and systems
WO2011106702A2 (en) 2010-02-25 2011-09-01 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
US20130195764A1 (en) * 2010-04-21 2013-08-01 President And Fellows Of Harvard College Nanoparticle Targeting to Ischemia for Imaging and Therapy
US20110311616A1 (en) * 2010-06-17 2011-12-22 Jeff Smith Targeting tumor associated macrophages using bisphosphonate-loaded particles
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
US9907758B2 (en) 2012-01-09 2018-03-06 Panjab University Department Of Biotechnology (Dbt) Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
EP2625966A1 (en) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
US10568975B2 (en) * 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
US9468681B2 (en) 2013-03-01 2016-10-18 California Institute Of Technology Targeted nanoparticles
CN105377942B (zh) * 2013-05-14 2018-07-31 加州理工学院 通过跨越血脑屏障的纳米颗粒递送治疗剂和显像剂的方法
WO2015175545A1 (en) 2014-05-12 2015-11-19 The Johns Hopkins University Highly stable biodegradable gene vector platforms for overcoming biological barriers
AU2016211696B2 (en) 2015-01-27 2018-05-10 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
ES2882255T3 (es) 2015-07-01 2021-12-01 California Inst Of Techn Sistemas de administración basados en polímeros de ácido múcico catiónicos
US10786465B2 (en) 2015-07-27 2020-09-29 The Texas A&M University System Polymer/copolymer nanoparticles conjugated to gambogic acid
CN109069872B (zh) * 2015-12-09 2021-07-13 得克萨斯州大学系统董事会 用于治疗疾病的聚合物药物递送系统
US20190381188A1 (en) 2018-06-13 2019-12-19 California Institute Of Technology Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same
US11738092B2 (en) 2019-12-04 2023-08-29 Dantari, Inc. Methods and compositions for synthesis of therapeutic nanoparticles
CN116808202B (zh) * 2023-04-28 2025-08-01 苏州大学 一种纳米硼递送剂及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021168A4 (en) * 1997-10-09 2006-08-30 Univ Vanderbilt MICRO AND NANOAPARTICULAR, POLYMERIC ADMINISTRATION SYSTEM
US7008645B2 (en) * 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
US6558702B2 (en) * 2001-04-13 2003-05-06 Alkermes Controlled Therapeutics, Inc. Method of modifying the release profile of sustained release compositions
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제
MXPA06012431A (es) * 2004-05-06 2007-01-17 Samyang Corp Sistema de administracion para agentes bioactivos con base en un portador de farmaco polimerico que comprende un polimero de bloque anfifilico y un derivado de acido polilactico.
EP1865928A1 (en) * 2005-03-17 2007-12-19 Elan Pharma International Limited Nanoparticulate biphosphonate compositions

Also Published As

Publication number Publication date
CN101500546A (zh) 2009-08-05
BRPI0716046A2 (pt) 2013-09-17
RU2009109353A (ru) 2010-09-27
EP2054043A2 (en) 2009-05-06
AR062452A1 (es) 2008-11-12
AU2007319701A1 (en) 2008-05-22
KR20090041437A (ko) 2009-04-28
CL2007002371A1 (es) 2008-08-08
MX2009001630A (es) 2009-02-23
WO2008060734A3 (en) 2008-07-10
US20100166865A1 (en) 2010-07-01
JP2010501004A (ja) 2010-01-14
TW200815047A (en) 2008-04-01
CA2659407A1 (en) 2008-05-22
WO2008060734A2 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
PE20080899A1 (es) Composiciones en nanoparticulas
Prasanna et al. Sustained release of amoxicillin from hydroxyapatite nanocomposite for bone infections
Zheng et al. 2D nanomaterials for tissue engineering and regenerative nanomedicines: recent advances and future challenges
Daneshmandi et al. Graphene‐based biomaterials for bone regenerative engineering: a comprehensive review of the field and considerations regarding biocompatibility and biodegradation
Choi et al. Supertough hybrid hydrogels consisting of a polymer double‐network and mesoporous silica microrods for mechanically stimulated on‐demand drug delivery
Hu et al. Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods via in situ hybridization: a potential material as internal fixation of bone fracture
Petrauskaite et al. Biomimetic mineralization on a macroporous cellulose‐based matrix for bone regeneration
Peña-Parás et al. Nanoclays for biomedical applications
Zhang et al. Sustained protein therapeutics enabled by self-healing nanocomposite hydrogels for non-invasive bone regeneration
Wu et al. Mussel-inspired multifunctional surface through promoting osteogenesis and inhibiting osteoclastogenesis to facilitate bone regeneration
WO2007070547A3 (en) Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
Yang et al. Sustained release of BMSC‐EVs from 3D printing gel/HA/nHAP scaffolds for promoting bone regeneration in diabetic rats
Zhao et al. Advances on graphene-based nanomaterials and mesenchymal stem cell-derived exosomes applied in cutaneous wound healing
BRPI0822162B8 (pt) composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal
BRPI0716156A8 (pt) Composição compreendendo nanopartículas tipo núcleo-casca, método para a preparação da referida composição e revestimento
Levingstone et al. Hydroxyapatite sonosensitization of ultrasound‐triggered, thermally responsive hydrogels: An on‐demand delivery system for bone repair applications
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
Sun et al. Continuous‐gradient mineralized hydrogel synthesized via gravitational osmosis for osteochondral defect repair
BR0312572A (pt) Derivados de azabiciclo como antagonistas de receptores muscarìnicos
Sun et al. Inspired by the periodontium: a universal bacteria-defensive hydrogel for preventing percutaneous device-related infection
Erezuma et al. Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering
Köse et al. Stem cell and advanced nano bioceramic interactions
Di Crescenzo et al. Graphene oxide foils as an osteoinductive stem cell substrate
BRPI0518999A2 (pt) composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
Wu et al. Antibacterial collagen composite membranes containing minocycline

Legal Events

Date Code Title Description
FD Application declared void or lapsed